Aaron is a postdoctoral fellow in the lab of Dr. Carla Kim in the Stem Cell Program at Boston Children’s Hospital and the Department of Genetics at Harvard Medical School. Using a combination of single-cell RNA-seq, computational analysis, mouse models, and lung organoid cultures he studies the role of cell-to-cell signaling during lung cancer initiation and progression. Aaron aims to understand the biology of early-stage cancer, discover secreted factors that can be used in early-stage diagnostics, and to identify new targets for drug development that interfere with the lung cancer microenvironment. His research is supported by the Damon Runyon Cancer Research Foundation and Burroughs Wellcome Fund. He will be on the job market over the next few years and always open to discussing faculty opportunities.